Literature DB >> 30745601

Chronic heart failure in the elderly: still a current medical problem.

Agnieszka Skrzypek1, Magdalena Mostowik2, Marta Szeliga2, Magdalena Wilczyńska-Golonka3, Dorota Dębicka-Dąbrowska2, Jadwiga Nessler4.   

Abstract

Congestive heart failure (CHF) is the final stage in several heart diseases. The diagnosis of CHF in older patients is a challenge. Preserved left ventricular systolic function is a characteristic type of CHF in seniors. The purpose of the study was to characterize elderly patients with CHF and to highlight specific features of the conditions in seniors. e most common etiology of HF in this group of patients is hypertension and coronary heart disease. In seniors atypical presentations of chronic heart failure is much more common than in younger patients. Malnutrition, limitations of exercise and sedentary lifestyles or comorbid diseases have an influence on asymptomatic, early stage of HF. There are better outcomes of treatment in obese individuals. It is called the obesity paradox. Open communication with a patient and his/her family may improve their response to therapy. When heart failure becomes an incurable disease and aggressive treatment is ineffective, palliative care should be considered in end-of-life heart failure patients. The goal of treatment in the remaining moments of life last moments of life should be maximizing the patient's comfort.

Entities:  

Keywords:  cachexia; congestive heart failure; palliative care; seniors

Mesh:

Year:  2018        PMID: 30745601

Source DB:  PubMed          Journal:  Folia Med Cracov        ISSN: 0015-5616


  10 in total

1.  Ventricular Arrhythmias in Seniors with Heart Failure: Present Dilemmas and Therapeutic Considerations: A Systematic Review.

Authors:  Tuoyo O Mene-Afejuku; Abayomi O Bamgboje; Modele O Ogunniyi; Ola Akinboboye; Uzoma N Ibebuogu
Journal:  Curr Cardiol Rev       Date:  2022

2.  Clinical significance of sFRP5, RBP-4 and NT-proBNP in patients with chronic heart failure.

Authors:  Yu An; Qingsong Wang; Hong Wang; Na Zhang; Fengming Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Influence of targeted motivational interviewing on self-care level and prognosis during nursing care of chronic heart failure.

Authors:  Jianfei Wu; Yilan Yu; Huan Xu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  Efficacy of different telemonitoring strategies on chronic heart failure care: A protocol for systematic review and meta-analysis.

Authors:  Aichun Wu; Hongbing Li
Journal:  Medicine (Baltimore)       Date:  2022-04-08       Impact factor: 1.817

5.  Clinical significance of the long non-coding RNA NEAT1/miR-129-5p axis in the diagnosis and prognosis for patients with chronic heart failure.

Authors:  Haohua Zhang; Nianli Zhang; Wenbin Jiang; Xiaoqin Lun
Journal:  Exp Ther Med       Date:  2021-03-19       Impact factor: 2.751

6.  LDL‑induced NLRC3 inflammasome activation in cardiac fibroblasts contributes to cardiomyocytic dysfunction.

Authors:  Peng Wang; Wenbo Zhang; Zhen Feng; Jian Zhang; Ying Sun; Wei Zhang
Journal:  Mol Med Rep       Date:  2021-05-26       Impact factor: 2.952

7.  Effects of enteral nutrition on heart function, inflammatory markers and immune function in elderly patients with chronic heart failure.

Authors:  Dan Zhang; Hongli Li; Xiang Tian; Sujuan Zhang
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

8.  Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways.

Authors:  Xiaowen Wang; Kaiyun Yan; Cuifeng Wen; Jiaqi Wang
Journal:  Cardiovasc Ther       Date:  2022-03-12       Impact factor: 3.023

9.  The effectiveness of eHealth self-management interventions in patients with chronic heart failure: Protocol for a systematic review and meta-analysis.

Authors:  Siru Liu; Jili Li; Zhan Qu; Runyi Li; Jialin Liu
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

Review 10.  Empagliflozin-A New Chance for Patients with Chronic Heart Failure.

Authors:  Klaudia Kowalska; Justyna Walczak; Joanna Femlak; Ewelina Młynarska; Beata Franczyk; Jacek Rysz
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.